Global Stock News

What Would Full FDA Approval of Pfizer’s COVID Vaccine Mean for the Stock?

Article feature image

What Would Full FDA Approval of Pfizer’s COVID Vaccine Mean for the Stock?

The clock is now ticking for a Food and Drug Administration decision on full approval for the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX). The vaccine is currently on the market in the U.S. under the FDA’s Emergency Use Authorization…

Click here to view the original article.

Share this article

Scroll to Top